A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 67
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : hMLH1
Long Form : human mutL homolog 1
No. Year Title Co-occurring Abbreviation
2020 DNMT1 promotes cell proliferation via methylating hMLH1 and hMSH2 promoters in EGFR-mutated non-small cell lung cancer. DNMT1, hMSH2, NSCLC
2019 The prevalence and persistence of aberrant promoter DNA methylation in benzene-exposed Chinese workers. BQ, HQ, HRM, LINE-1
2018 Association Between hMLH1 Promoter Methylation and Risk of Gastric Cancer: A Meta-Analysis. HP, MSI, OR
2018 Promoter methylation of human mutL homolog 1 and colorectal cancer risk: A meta-analysis. CIs, CRC, ORs
2018 Relevance of hMLH1 -93G>A, 655A>G and 1151T>A polymorphisms with colorectal cancer susceptibility: a meta-analysis based on 38 case-control studies. CI, CRC, OR
2017 Differential Expression and Clinical Significance of DNA Methyltransferase 3B (DNMT3B), Phosphatase and Tensin Homolog (PTEN) and Human MutL Homologs 1 (hMLH1) in Endometrial Carcinomas. DNMT3B, ECs, NECs, OS, PTEN
2017 In vitro study of human mutL homolog 1 hypermethylation in inducing drug resistance of esophageal carcinoma. DDP, MSP
2017 Mismatch Repair Protein hMLH1, but not hMSH2, Enhances Estrogen-Induced Apoptosis of Colon Cancer Cells. ERbeta, HRT, MMR
2017 Relationship Between Human mutL Homolog 1 (hMLH1) Hypermethylation and Colorectal Cancer: A Meta-Analysis. CIs, MSI, ORs
10  2017 RG108 induces the apoptosis of endometrial cancer Ishikawa cell lines by inhibiting the expression of DNMT3B and demethylation of HMLH1. DNMT, FBS, MSP, MTT, RPMI-1640
11  2016 Human MutL homolog 1 immunoexpression in oral leukoplakia and oral squamous cell carcinoma: A prospective study in Indian population. OL, OSCC
12  2016 Reappraisal of hMLH1 promoter methylation and protein expression status in the serrated neoplasia pathway. HPs, SSL
13  2015 DNA methylation of hMLH1 correlates with the clinical response to cisplatin after a surgical resection in Non-small cell lung cancer. ---
14  2015 Human mutL homolog 1 expression characteristic and prognostic effect on patients with sporadic colorectal cancer. DFS, OS
15  2014 Aberrant DNA methylation of MGMT and hMLH1 genes in prediction of gastric cancer. CI, OR
16  2014 Chemotherapy induced microsatellite instability and loss of heterozygosity in chromosomes 2, 5, 10, and 17 in solid tumor patients. hMSH2, hMSH6, hPMS2, LOH, MMR, MSI
17  2014 Clinical significance of mismatch repair gene expression in sporadic colorectal cancer. BMI, DFS, hMSH, hPSM2, MMR, MMRP
18  2014 Epithelial-mesenchymal transition in colorectal cancer tissue of patients with Lynch syndrome. CRC, EMT, hMSH2, MMP-7, TGFbetaRII, TIMP-2
19  2014 p16 Methylation is associated with chemosensitivity to fluorouracil in patients with advanced gastric cancer. AGC
20  2014 Promoter methylation status of MGMT, hMSH2, and hMLH1 and its relationship to corresponding protein expression and TP53 mutations in human esophageal squamous cell carcinoma. hMSH2, MGMT, PCR
21  2014 [Effects of gossypol acetic acid on the proliferation and methylation level of the human MutL homologue 1 gene in human tongue carcinoma cell line Tca8113]. GAA, nMSP
22  2013 MicroRNA-31-5p modulates cell cycle by targeting human mutL homolog 1 in human cancer cells. miRNAs, MMR, NSCLC
23  2013 The significance of mismatch repair genes in gastric cancer. hMSH2, MMR, MSI
24  2012 A meta-analysis of the prevalence of somatic mutations in the hMLH1 and hMSH2 genes in colorectal cancer. CRC, hMSH2, MSI, MSS
25  2012 Involvement of pelvic inflammation-related mismatch repair abnormalities and microsatellite instability in the malignant transformation of ovarian endometriosis. hMSH2, MMR, MSI-S
26  2012 Mismatch repair proteins hMLH1 and hMSH2 are differently expressed in the three main subtypes of sporadic renal cell carcinoma. EMAST, hMSH2, MMR, MSI, RCC
27  2012 [hMLH1 gene promoter methylation in joint cartilage in patients with osteoarthritis]. MSP, OA
28  2011 Aberrant methylation of different DNA repair genes demonstrates distinct prognostic value for esophageal cancer. ESCC, hMSH2, MMR, PCR
29  2011 Prognostic value of H-MLH1 after adjusting for RPA class in GBM patients. GBM
30  2010 Microsatellite instability and hMLH1 and hMSH2 expression in renal tumors. hMSH2, MMR, MSI
31  2010 Polymorphisms in hMSH2 and hMLH1 and response to platinum-based chemotherapy in advanced non-small-cell lung cancer patients. hMSH2, NSCLC, SNPs
32  2009 DNA mismatch repair (MMR)-dependent 5-fluorouracil cytotoxicity and the potential for new therapeutic targets. FdCyd, FdUMP, FP, FUra, MMR
33  2009 Epigenetic deregulation of DNA repair and its potential for therapy. BRCA1, MGMT, WRN
34  2009 Invasion associated up-regulation of nuclear factor kappaB target genes in colorectal cancer. CRC, IF, NF-kappaB, TC
35  2008 Epigenetic-genetic interactions in the APC/WNT, RAS/RAF, and P53 pathways in colorectal carcinoma. APC, CIMP, OR
36  2008 Hypermethylation status of APC inversely correlates with the presence of submucosal invasion in laterally spreading colorectal tumors. APC, CGIs, LSTs, MSP
37  2008 Immunoexpression of hMSH2 and hMLH1 in oral squamous cell carcinoma and its relationship to histological grades of malignancy. C/S, hMSH2, ITF, OSCC
38  2007 Inactivation of human mutL homolog 1 and mutS homolog 2 genes in head and neck squamous cell carcinoma tumors and leukoplakia samples by promoter hypermethylation and its relation with microsatellite instability phenotype. hMSH2, HNSCC, MIN
39  2006 Aberrant promoter methylation of multiple genes in malignant ovarian tumors and in ovarian tumors with low malignant potential. BRCA1, ERalpha, GSTP1, IGFBP-3, MI
40  2006 hMLH1 and MGMT inactivation as a mechanism of tumorigenesis in monoclonal gammopathies. MGMT
41  2006 HOXA5 regulates hMLH1 expression in breast cancer cells. ---
42  2006 Regional DNA hypermethylation and DNA methyltransferase (DNMT) 1 protein overexpression in both renal tumors and corresponding nontumorous renal tissues. DNMT, MINT, RCCs, THBS1, VHL
43  2006 Regulation of hMSH2 and hMLH1 expression in the human colon cancer cell line SW1116 by DNA methyltransferase 1. DNMT1, hMSH2, MMR, MSP
44  2005 Cigarette smoking and colorectal cancer: APC mutations, hMLH1 expression, and GSTM1 and GSTT1 polymorphisms. APC, CI, GSTM1, GSTT1, IRR
45  2005 Microsatellite instability is linked to loss of hMLH1 expression in advanced gastric cancers: lack of a relationship with the histological type and phenotype. MSI
46  2005 Molecular pathological subclassification of mucinous adenocarcinoma of the colorectum. HGM, MAC, MSI
47  2005 Promoter methylation of the hMLH1 gene and protein expression of human mutL homolog 1 and human mutS homolog 2 in resected esophageal squamous cell carcinoma. hMSH2
48  2005 Reduced expression of human mismatch repair genes in adult T-cell leukemia. ATL, hMSH2, hPMS1, MMR, RT-PCR
49  2005 [Expression of cyclooxygenase-2, hMLH1 and hMSH2 proteins, and their relationship with microsatellite instability in gastric carcinoma]. COX-2, GC, hMSH2, MSI, MSI-L, MSS
50  2004 Increased DNA methyltransferase 1 (DNMT1) protein expression correlates significantly with poorer tumor differentiation and frequent DNA hypermethylation of multiple CpG islands in gastric cancers. DNMT1, EBV, MINT, THBS1
51  2003 Combined loss of expression of O6-methylguanine-DNA methyltransferase and hMLH1 accelerates progression of hepatocellular carcinoma. HCC
52  2003 DNA mismatch repair (MMR) mediates 6-thioguanine genotoxicity by introducing single-strand breaks to signal a G2-M arrest in MMR-proficient RKO cells. 6-TG, MMR, SSBs
53  2003 Human mismatch-repair protein MutL homologue 1 (MLH1) interacts with Escherichia coli MutL and MutS in vivo and in vitro: a simple genetic system to assay MLH1 function. HNPCC, MLH1, MMR
54  2003 Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. DNMT, EGCG, RARbeta
55  2002 hMLH1 and hMSH2 gene mutation in Brazilian families with suspected hereditary nonpolyposis colorectal cancer. CRC, hMSH2, HNPCC
56  2002 Loss of heterozygosity, microsatellite instability, and mismatch repair protein alterations in the radial growth phase of cutaneous malignant melanomas. CMMs, hMSH2, hMSH6, LOH, MMR, MSI, RGP
57  2002 Mismatch repair genes hMLH1 and hMSH2 and colorectal cancer: a HuGE review. hMSH2
58  2001 CpG island methylation in premalignant stages of gastric carcinoma. DAP, THBS1, TIMP-3
59  2001 Expression of hMLH1 and hMSH2 and assessment of microsatellite instability in testicular and mediastinal germ cell tumours. hMSH2
60  2001 Hypermethylation of the hMLH1 gene promoter is associated with microsatellite instability in early human gastric neoplasia. MSI, MSI-S
61  2001 Promoter methylation status of the DNA repair genes hMLH1 and MGMT in gastric carcinoma and metaplastic mucosa. ---
62  2001 Reduced expression of hMLH1 and hMSH2 gene products in high-grade hepatocellular carcinoma. HCC, hMSH2
63  2001 Sporadic colorectal cancers with microsatellite instability and their possible origin in hyperplastic polyps and serrated adenomas. MSI, MSS
64  2000 Genetic alterations of sporadic colorectal cancer with microsatellite instability, especially characteristics of primary multiple colorectal cancers. Bax, hMSH2, hMSH3, hMSH6, IGF II R, MSI, MSI-H, MSS, TGF beta R II
65  1999 Immunohistochemistry for hMLH1 and hMSH2: a practical test for DNA mismatch repair-deficient tumors. DNA, hMSH2, HNPCC
66  1998 Microsatellite instability and loss of heterozygosity at DNA mismatch repair gene loci occurs during hepatic carcinogenesis. APC, HCC, hMSH2
67  1997 Mutations and loss of expression of a mismatch repair gene, hMLH1, in leukemia and lymphoma cell lines. PCR-SSCP